FORWARD FEATURES CALENDAR

Share this article?

NEWSLETTER

Like this article?

Sign up to our free newsletter

SK Capital appoints two managing directors

Private equity firm SK Capital Partners has expanded its investment team with the additions of Aaron Davenport and Jim Marden as managing directors.

Both Davenport and Marden previously led the healthcare investing effort at Arsenal Capital Partners, where they worked closely with Barry Siadat and Jack Norris, two managing directors at SK Capital.

"Aaron, Jim and I collaborated on several successful investments while at Arsenal," says Siadat. "I have the utmost respect for their investment judgment and deal execution capabilities and am excited to have them become an integral part of SK Capital going forward."

"Jim and I are very pleased to be working with Barry and Jack again to build on our successful track record of sourcing and improving niche leading companies and generating attractive returns for our investors," says Davenport.

Prior to joining SK Capital, Davenport was a principal at Arsenal Capital Partners, where he co-led Arsenal’s healthcare investing efforts and served on the firm’s operating and investment committees. Davenport was with Arsenal from 2001 to 2009. Prior to joining Arsenal, Davenport was a healthcare industry strategy consultant with Braun Consulting and was previously director of business strategy and development for CB Richard Ellis/Whittier Partners.

Prior to joining SK Capital, Marden was a managing director at Arsenal Capital Partners from 2001 to 2008, where he served on the firm’s operating and investment committees and led their healthcare investing efforts. Prior to Arsenal, Marden was the executive vice president of corporate development of Medical Logistics, a transportation and logistics company focused on healthcare distribution.

Like this article? Sign up to our free newsletter

FEATURED

MOST RECENT

FURTHER READING